Shu Ning
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Epigenetics and DNA Methylation 4
- Glutathione Transferases and Polymorphisms 3
- Genomics, phytochemicals, and oxidative stress 3
-
- Prostate Cancer Treatment and Research 13
- Co-authors
- Chung S. Yang (18 shared papers)John F. Brady (7 shared papers)Christopher Patten (2 shared papers)Anthony Y.H. Lu (1 shared paper)Paul E. Thomas (4 shared papers)Mong-Heng Wang (2 shared papers)Jun-Yan Hong (3 shared papers)Mao‐Jung Lee (4 shared papers)
- Journals
- Archives of Biochemistry and Biophysics (4 papers)Molecular Cancer Therapeutics (4 papers)Cancer Research (3 papers)Oncogene (3 papers)Toxicology and Applied Pharmacology (3 papers)
- Partner nations
- United StatesChinaEgypt
In The Last Decade
Shu Ning
39 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 85
- Pharmacology 611
- Biochemistry 186
- Cancer Research 213
- Pathology and Forensic Medicine 194
- Oncology 254
Countries citing papers authored by Shu Ning
This map shows the geographic impact of Shu Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Ning more than expected).
Fields of papers citing papers by Shu Ning
This network shows the impact of papers produced by Shu Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Ning. The network helps show where Shu Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Shu Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 127 | |
| 2 | 1991 | 111 | |
| 3 | 1991 | 108 | |
| 4 | 1991 | 94 | |
| 5 | 1990 | 66 | |
| 6 | Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate. | 1993 | 65 |
| 7 | 1992 | 62 | |
| 8 | 2020 | 60 | |
| 9 | 1990 | 58 | |
| 10 | Metabolism of carcinogenic nitrosamines by rat nasal mucosa and the effect of diallyl sulfide. | 1991 | 58 |
| 11 | Regulation of N-nitrosodimethylamine demethylase in rat liver and kidney. | 1987 | 54 |
| 12 | 1993 | 53 | |
| 13 | 1989 | 48 | |
| 14 | Metabolism and activation of N-nitrosodimethylamine by hamster and rat microsomes: comparative study with weanling and adult animals. | 1987 | 47 |
| 15 | 1990 | 43 | |
| 16 | 1992 | 41 | |
| 17 | 1992 | 37 | |
| 18 | Molecular basis for the sex-related difference in renal N-nitrosodimethylamine demethylase in C3H/HeJ mice. | 1989 | 36 |
| 19 | 1990 | 23 | |
| 20 | 2021 | 20 |
About Shu Ning
Shu Ning is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Pharmacology, Oncology and Endocrinology, Diabetes and Metabolism, having authored 41 papers that have together received 1.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (13 papers), Pharmacogenetics and Drug Metabolism (12 papers), PARP inhibition in cancer therapy (6 papers), Epigenetics and DNA Methylation (4 papers), Hormonal and reproductive studies (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Glutathione Transferases and Polymorphisms (3 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). The work is most often cited by research in Pharmacology (611 citations), Biochemistry (186 citations), Cancer Research (213 citations), Pathology and Forensic Medicine (194 citations) and Oncology (254 citations). Shu Ning has collaborated with scholars based in United States, China and Egypt. Frequent co-authors include Chung S. Yang, John F. Brady, Christopher Patten, Anthony Y.H. Lu, Paul E. Thomas, Mong-Heng Wang, Jun-Yan Hong, Mao‐Jung Lee, Carol B. Pantuck and Eugene J. Pantuck. Their work appears in journals such as Archives of Biochemistry and Biophysics, Molecular Cancer Therapeutics, Cancer Research, Oncogene and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.